Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Assets: 2019-2022

Historic Assets for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $490.9 million.

  • ADC Therapeutics' Assets fell 12.20% to $466.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $466.9 million, marking a year-over-year decrease of 12.20%. This contributed to the annual value of $490.9 million for FY2022, which is 79330.62% up from last year.
  • Per ADC Therapeutics' latest filing, its Assets stood at $490.9 million for FY2022, which was up 79,330.62% from $617,972 recorded in FY2021.
  • ADC Therapeutics' 5-year Assets high stood at $490.9 million for FY2022, and its period low was $137,682 during FY2019.
  • Over the past 2 years, ADC Therapeutics' median Assets value was $245.7 million (recorded in 2021), while the average stood at $245.7 million.
  • Data for ADC Therapeutics' Assets shows a peak YoY spiked of 79,330.62% (in 2022) over the last 5 years.
  • Over the past 3 years, ADC Therapeutics' Assets (Yearly) stood at $137,682 in 2019, then reached $617,972 in 2021, then soared by 79,330.62% to $490.9 million in 2022.